Background The COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although …

Background and objectives One year after the onset of the coronavirus disease 2019 (COVID-19)
pandemic, we aimed to summarize the frequency of neurologic manifestations …

There is accumulating evidence of the neurological and neuropsychiatric features of infection
with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the …

Historical epidemiological perspectives from past pandemics and recent neurobiological
evidence link infections and psychoses, leading to concerns that COVID-19 will present a …

Clinicians are increasingly recognising neurological presentations occur in some patients. 1
A case series from Wuhan described associated neurological syndromes (eg,‘dizziness’ …

Background. Encephalitis is parenchymal brain inflammation, commonly due to herpes
simplex virus (HSV). Key host inflammatory mediators and their relationship to blood-brain …

Neurocognitive (NC) impairment (NCI) occurs commonly in people living with HIV. Despite
substantial effort, no biomarkers have been sufficiently validated for diagnosis and prognosis …

Background Central nervous system infections can have devastating clinical outcomes if not
diagnosed and treated promptly. There is a documented gap between recommended and …

We report the case of a 35-year-old male with COVID-19 encephalitis presenting as a stroke
mimic with sudden-onset expressive and receptive dysphasia, mild confusion and right arm …

Background Identification and tracking of important communicable diseases is pivotal to our
understanding of the geographical distribution of disease, the emergence and spread of …